Target intelligence / Profile preview

RNA, U6 small nuclear 1023, pseudogene (RNU6-1023P)

Target
RNU6-1023P
Molecular classification
Other, Pseudogene, Non-coding RNA (derivative of small nuclear RNA)
01

Overview

RNU6-1023P is a processed pseudogene, meaning it is a nonfunctional copy of the U6 small nuclear RNA gene that has been integrated into the genome through retrotransposition, often mediated by LINE-1 elements[2][5]. Functional U6 snRNA is essential for the splicing of pre-mRNA and forms part of the catalytic center of the spliceosome, but pseudogene derivatives like RNU6-1023P do not produce a functional RNA and are considered molecular fossils. Such pseudogenes may serve as markers of retrotransposition activity in evolutionary or genome studies, but they have no active biological, molecular, or therapeutic role[2][3]. Key distinctions: - Functional U6 snRNA is vital for mRNA splicing, but pseudogenes like RNU6-1023P do not participate in this process[1][3]. - RNU6-1023P is one of many U6 snRNA-derived pseudogenes prevalent in the human and other mammalian genomes, generated via retrotransposition events and not retained for molecular function[2][5]. - This entry is based on genomic classification rather than pharmacological, biological, or therapeutic relevance. Summary: RNU6-1023P represents a genomic processed pseudogene, not a working receptor, enzyme, or therapeutic target. All entries relating to drugs, mechanism of action, disease roles, and biomarkers should be considered null, as the pseudogene does not participate in molecular or cellular activity relevant to therapeutics[2][3].

Other names
RNU6-1023PRNA, U6 small nuclear 1023, pseudogeneU6 snRNA pseudogene 1023

Beyond the preview

Go deeper on RNA, U6 small nuclear 1023, pseudogene (RNU6-1023P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1023, pseudogene (RNU6-1023P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call